These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 177335)

  • 21. [Pharmacological properties and clinical use of xanthinol nicotinate].
    Mashkovskiĭ MD; Iuzhakov SD; Absava GI; Erokhina LG; Lebedeva NV
    Klin Med (Mosk); 1984 Nov; 62(11):30-4. PubMed ID: 6097742
    [No Abstract]   [Full Text] [Related]  

  • 22. [Bioavailability and tolerance of xanthinol nicotinate depot preparations. Comparison of a conventional 500 mg xanthinol nicotinate depot tablet with new 500 mg and 1 g depot tablets].
    von Schrader HW; Buscher G; Dierdorf D; Freytag A; Mügge H; Wolf D
    Arzneimittelforschung; 1985; 35(9):1468-72. PubMed ID: 4084347
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Xanthinol nicotinate in peripheral vascular disease.
    Davis E; Rozov H
    Practitioner; 1975 Dec; 215(1290):793-8. PubMed ID: 772653
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Favourable effect of combined Miscleron-Xavin treatment on HDL-cholesterol level.
    Pados G; Kusztos D; Németh-Csóka M; Valyon M; Farkas K
    Ther Hung; 1983; 31(2):59-61. PubMed ID: 6571183
    [No Abstract]   [Full Text] [Related]  

  • 25. Comparative effects of placebo and plain and slow-release tablets of xanthinol nicotinate on exercise tolerance in normal human subjects.
    Sharma PL
    Int J Clin Pharmacol Biopharm; 1978 Jan; 16(1):19-21. PubMed ID: 631966
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical comparison of dextran 40 and xantinol nicotinate in the treatment of sudden deafness caused by shock waves (author's transl)].
    Martin G; Jacobs P
    Laryngol Rhinol Otol (Stuttg); 1977 Oct; 56(10):860-3. PubMed ID: 144224
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum profile of non-esterified fatty acids (NEFA) in patients with hyperlipoproteinemia under xantinol--nicotinate (XN) medication.
    Haacke H; Parwaresch MR; Mäder C
    Atherosclerosis; 1980 Sep; 37(1):77-85. PubMed ID: 7426090
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of xanthinol nicotinate treatment on platelet aggregation.
    Seidel G; Endell W
    Int J Clin Pharmacol Biopharm; 1977 Mar; 15(3):139-43. PubMed ID: 844933
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lipids and lipoproteins in hyperlipidemia type IIa during treatment with different lipid lowering drugs.
    Wechsler JG; Hutt V; Klör HU; Ditschuneit H
    Artery; 1980; 8(6):519-29. PubMed ID: 7259531
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Circulatory effects of xanthinol nicotinate in advanced pregnancy (author's transl)].
    Schwarz R; Retzke U; Lauckner W
    Zentralbl Gynakol; 1980; 102(8):446-51. PubMed ID: 7456902
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The observation of the influence of the unretarded form of xanthinol-niacinate (Complamine) in ulcus cruris venosum on the skin temperature of the lower extremities with the biochemical determination of the levels of the preparation (author's transl)].
    Resl V; Götzová ; Vitous J
    Cesk Dermatol; 1976 Dec; 51(6):389-93. PubMed ID: 1009598
    [No Abstract]   [Full Text] [Related]  

  • 32. Treatment of cerebral embolism in heart surgery.
    Bross W; Bross T; Koltowski R; Kustrzyski A; Olejak B; Dymala L; Masiak M; Crzereda T; Kibler J; Krupacz R; Ostapczuk S; Michel AJ
    Ann Chir Gynaecol Fenn; 1975; 64(5):280-3. PubMed ID: 1211834
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effect of complamin and prodectin on microcirculation and lipid metabolism in psoriasis patients].
    Rakhmatov AB; Bilash NV
    Vestn Dermatol Venerol; 1983 Apr; (4):15-8. PubMed ID: 6868813
    [No Abstract]   [Full Text] [Related]  

  • 34. [Prolonged clinical study of the LA, 313-B-xanthinol niacinate pentosan sulfonate ester combination in various forms of hypertension].
    Masso M; Gimeno Martínez J; Honorato J
    Rev Clin Esp; 1976 Jul; 142(2):157-61. PubMed ID: 968103
    [No Abstract]   [Full Text] [Related]  

  • 35. [Effect of diet and drug therapy on the level of high density lipoprotein cholesterol in patients with primary hyperlipoproteinemia].
    Padosh D; Kustosh D; Puchok I; Dem'ianova N; Audikovski M
    Klin Med (Mosk); 1981 Sep; 59(9):45-8. PubMed ID: 7311430
    [No Abstract]   [Full Text] [Related]  

  • 36. [Use of teonikol in bronchial asthma in children].
    Geppe NA; Sokolovskiĭ GA; Akhmatalieva MA
    Pediatriia; 1986 Dec; (12):52-3. PubMed ID: 3822709
    [No Abstract]   [Full Text] [Related]  

  • 37. [Chronic stimulation of the fibrinolytic system as supplementary treatment of intrauterine fetal hypotrophy].
    Uszyński M; Majczyńska W; Uszyński W; Kiełkowski A
    Ginekol Pol; 1988 Jul; 59(7):429-34. PubMed ID: 3234888
    [No Abstract]   [Full Text] [Related]  

  • 38. [Treatment of ischemic heart disease with complamine].
    Kuz'ko NV
    Vrach Delo; 1981 Jan; (1):82-4. PubMed ID: 7010784
    [No Abstract]   [Full Text] [Related]  

  • 39. [Complamin in the complex therapy of patients with chronic nonspecific prostatitis].
    Iunda IF; Israilov SR
    Vrach Delo; 1987 Nov; (11):64-7. PubMed ID: 3439130
    [No Abstract]   [Full Text] [Related]  

  • 40. [The influence of xanthinol nicotinate and of a hyperosmolar solution on the motility of the colon].
    Willmen HR; Kogel H
    Int J Clin Pharmacol Biopharm; 1976 Mar; 13(2):133-8. PubMed ID: 1254378
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.